| scholarly article | Q13442814 |
| P2093 | author name string | P Rotwein | |
| M A Lawlor | |||
| P2860 | cites work | Regulation of the MEF2 family of transcription factors by p38 | Q22008562 |
| Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors | Q22010041 | ||
| Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade | Q24314554 | ||
| Phosphorylation and activation of p70s6k by PDK1 | Q24323433 | ||
| p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps | Q24554203 | ||
| Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit | Q24554482 | ||
| Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function | Q24642759 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling | Q28144330 | ||
| bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out | Q28258591 | ||
| Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1 | Q28283323 | ||
| RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation | Q28287920 | ||
| Muscle differentiation: more complexity to the network of myogenic regulators. | Q52182756 | ||
| The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. | Q52195728 | ||
| "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II | Q68249860 | ||
| Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice | Q72223472 | ||
| Inactivation of MyoD-mediated expression of p21 in tumor cell lines | Q73885031 | ||
| Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway | Q77863031 | ||
| Molecular and cellular aspects of the insulin-like growth factor I receptor | Q28288023 | ||
| Insulin-like growth factors and their binding proteins: biological actions | Q28301853 | ||
| Regulation of protein kinase C zeta by PI 3-kinase and PDK-1 | Q28567633 | ||
| Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells | Q28575426 | ||
| p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor | Q28646220 | ||
| Cell cycle checkpoints: preventing an identity crisis | Q29547644 | ||
| Cellular survival: a play in three Akts | Q29547806 | ||
| Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle | Q29615169 | ||
| Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control | Q29616465 | ||
| The MyoD family and myogenesis: redundancy, networks, and thresholds | Q29618503 | ||
| Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) | Q29619910 | ||
| Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance | Q33588931 | ||
| Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation | Q33840167 | ||
| Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. | Q33957805 | ||
| Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. | Q33963275 | ||
| Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21 | Q33966727 | ||
| p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step | Q35186897 | ||
| p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells | Q36328385 | ||
| Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. | Q36382342 | ||
| The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells | Q36557701 | ||
| An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. | Q36730708 | ||
| RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts | Q36891609 | ||
| Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. | Q37170896 | ||
| The Rho family G proteins play a critical role in muscle differentiation | Q39574637 | ||
| MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation | Q40016694 | ||
| Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. | Q40300975 | ||
| Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. | Q40606607 | ||
| The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos | Q40642168 | ||
| Regulation and function of the Rho subfamily of small GTPases | Q40757570 | ||
| Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation | Q40868357 | ||
| Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. | Q40915594 | ||
| Induction of NF-kappaB by the Akt/PKB kinase | Q40950127 | ||
| Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis | Q40975177 | ||
| Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation | Q40989063 | ||
| A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis | Q41028565 | ||
| Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells | Q41039392 | ||
| Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts | Q41066577 | ||
| Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases | Q41079552 | ||
| Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation | Q41164370 | ||
| Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors | Q41169594 | ||
| Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis | Q41173042 | ||
| Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells | Q41175824 | ||
| Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts | Q41199254 | ||
| Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage | Q41219482 | ||
| p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells | Q41368682 | ||
| Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. | Q41368691 | ||
| IGF-I is required for normal embryonic growth in mice | Q41510465 | ||
| The role of the IGF-I receptor in apoptosis. | Q41510718 | ||
| p21/p53, cellular growth control and genomic integrity | Q41710984 | ||
| p21: structure and functions associated with cyclin-CDK binding. | Q41744170 | ||
| The expanding role of cell cycle regulators | Q48005050 | ||
| Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. | Q48289809 | ||
| pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis | Q48852526 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1131-1140 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways | |
| P478 | volume | 151 |
| Q82797286 | Administration of granulocyte colony-stimulating factor facilitates the regenerative process of injured mice skeletal muscle via the activation of Akt/GSK3alphabeta signals |
| Q39316242 | Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway |
| Q91627122 | Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy |
| Q33992551 | Cdo interacts with APPL1 and activates Akt in myoblast differentiation |
| Q54472052 | Ciliary neurotrophic factor (CNTF) promotes skeletal muscle progenitor cell (MPC) viability via the phosphatidylinositol 3-kinase-Akt pathway. |
| Q36861023 | Clinical, agricultural, and evolutionary biology of myostatin: a comparative review |
| Q40036226 | Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. |
| Q48130018 | Different Effects of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-2 on Myogenic Differentiation of Human Mesenchymal Stem Cells. |
| Q28213611 | Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells |
| Q73350405 | Early Posthatch Feeding Stimulates Satellite Cell Proliferation and Skeletal Muscle Growth in Turkey Poults |
| Q42434917 | Expression of p21(waf1/cip1), p27 (kip1), p63 and androgen receptor in low and high Gleason score prostate cancer. |
| Q39127452 | Geometric control of myogenic cell fate |
| Q48028666 | IGF-1 activates p21 to inhibit UV-induced cell death. |
| Q57268523 | IGF-1 induces human myotube hypertrophy by increasing cell recruitment |
| Q28591416 | IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop |
| Q34994347 | Identification of differentially regulated secretome components during skeletal myogenesis |
| Q64235388 | Insulin-Like Growth Factor Binding Protein-6 Promotes the Differentiation of Placental Mesenchymal Stem Cells into Skeletal Muscle Independent of Insulin-Like Growth Factor Receptor-1 and Insulin Receptor |
| Q35586415 | Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation |
| Q37733826 | Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation |
| Q53852590 | Insulin‐like growth factor‐II gene polymorphism is associated with primary open angle glaucoma |
| Q34049304 | Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization |
| Q35101924 | Justification for antioxidant preconditioning (or how to protect insulin-mediated actions under oxidative stress). |
| Q39202734 | Long-term muscle-derived cell culture: multipotency and susceptibility to cell death stimuli |
| Q41159428 | Modulation of satellite cells activity and MyoD in rat thyroarytenoid muscle after reinnervation |
| Q34521644 | Muscle cell survival mediated by the transcriptional coactivators p300 and PCAF displays different requirements for acetyltransferase activity |
| Q36324105 | Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice |
| Q39674949 | Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. |
| Q28594645 | NET37, a nuclear envelope transmembrane protein with glycosidase homology, is involved in myoblast differentiation |
| Q39634639 | PI3K p110 alpha and p110 beta have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts |
| Q37465852 | PKN2 and Cdo interact to activate AKT and promote myoblast differentiation. |
| Q35796563 | Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation |
| Q28204258 | Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts |
| Q36943315 | Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis |
| Q36325079 | Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors |
| Q79091355 | Responsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle |
| Q38805063 | Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics |
| Q42242386 | Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation |
| Q54709855 | Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. |
| Q34312093 | The multifunctional role of IGF-1 in peripheral nerve regeneration |
| Q28593716 | The small muscle-specific protein Csl modifies cell shape and promotes myocyte fusion in an insulin-like growth factor 1-dependent manner |
| Q50969431 | Transient upregulation of connexin43 gap junctions and synchronized cell cycle control precede myoblast fusion in regenerating skeletal muscle in vivo. |
Search more.